Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 251 - 255 of 255 in total
Lefamulin is a pleuromutilin antibiotic used for the treatment of bacterial community-acquired pneumonia. A pleuromotilin is a more recently developed type of antibiotic that is derived from the fungus, Pleurotus mutilus. Lefamulin is available in intravenous and oral preparations and was granted FDA approval in August 2019. This drug is...
Approved
Investigational
Matched Description: … A pleuromotilin is a more recently developed type of antibiotic that is derived from the fungus, Pleurotus ... [A183206] Lefamulin is available in intravenous and oral preparations and was granted FDA approval in ... Lefamulin is a pleuromutilin antibiotic used for the treatment of bacterial community-acquired pneumonia …
QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies that is designed to enhance the body’s immune response to the antigen contained within the treatment. It is the leading member of the Stimulon family of adjuvants. As a vaccine additive, it is currently being...
Investigational
Matched Description: … QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies ... that is designed to enhance the body’s immune response to the antigen contained within the treatment ... As a vaccine additive, it is currently being evaluated in clinical trials in a variety of disease areas …
Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin alpha 1. Thymosin alpha 1 is an acetylated polypeptide. Thymosin alpha 1 is now approved in 35 developing countries for the treatment of Hepatitis B and C. It is also used to boost the...
Investigational
Matched Description: … Thymosin alpha 1 is now approved in 35 developing countries for the treatment of Hepatitis B and C. ... Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin ... alpha 1. …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Hormones, Hormone Substitutes, and Hormone Antagonists …
BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
Investigational
Matched Description: … BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
N-methyl-D-aspartate (NMDA) receptors (NMDARs) are members of the ionotropic glutamate receptor family, with key roles in brain development and neurological function.[A220118, A220128] NMDARs are heterotetramers that typically involve a dimer of dimers of both GluN1 and GluN2A-D subunits, with each subunit itself composed of an N-terminal domain (NTD), a ligand-binding...
Investigational
Withdrawn
Matched Iupac: … 4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol …
Matched Description: … and GluN2A-D subunits, with each subunit itself composed of an N-terminal domain (NTD), a ligand-binding ... with the influenza strain H5N1, ifenprodil was found to have a protective effect against H5N1-induced ... domain (LBD), a transmembrane domain, and a C-terminal cytoplasmic domain. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Displaying drugs 251 - 255 of 255 in total